[email protected]
CDI - Contrive Datum Insights
Agriculture

Nematicides Market Size, Growth Rate and Forecast to 2034: Drivers, Risks and Regional Demand

Nematicides revenue is forecast to reach USD 4.16 billion by 2034 at a 6.31% CAGR; this analysis covers the drivers, the bear case and where the growth sits by region and product type.

Published: Industry: AgricultureRead time: ~5 min

Nematicides protect crops from plant-parasitic nematodes, and the category sits in the agriculture industry alongside seed, crop protection and biological inputs. The nematicides market starts the forecast period at USD 2.4 billion in 2025 and ends 2034 at USD 4.16 billion. This article sets out how that path is built, what could bend it and which regions and product types carry it.

Market size and growth rate

The base year is 2025, the historical series runs 2020 to 2024 and the forecast covers 2026 to 2034. Revenue was USD 1.92 billion in 2020 and USD 2.29 billion in 2024. It then reached USD 2.4 billion in 2025.

The history already compounds at 4.56% before the forecast begins. The forecast period runs at a CAGR of 6.31% and is applied flat across all nine years, ending 2034 at USD 4.16 billion. A flat rate is a modelling choice, and it rests here on a series that has grown without a break. The forecast does not depend on a turnaround in a market that had been shrinking.

Two other cases sit around the base case, both built from the same USD 2.4 billion starting point. The bear case ends 2034 at USD 3.5 billion. The upside case ends at USD 4.59 billion. The spread between the three is the practical range for planning.

What is driving it

The growth is not spread evenly across product types. Microbial Biological Nematicides is the line pulling the market average up. It grows at 11.08% against the market's 6.31%, moving from USD 0.336 billion in 2025 to USD 0.874 billion in 2034. Its share of revenue goes from 14% to 21% over the same period.

The report draws a conclusion from that gap. At the other end of the product type axis the growth rate is 0.43%, so the market's 6.31% holds only if the fast line keeps its pace. A supplier's own growth rate depends on its exposure to that line. The market-wide figure tells a supplier much less.

The upside case adds a second set of drivers. It assumes faster registration of new chemistries and biologicals, and tighter limits on older products that push growers to pay for replacements. It also assumes wider nematode pressure that lifts both treated area and realised prices. None of these is assumed in the base case.

Readers following agricultural inputs more broadly may also want the microgreens market, a separate agriculture segment forecast at USD 7.98 billion by 2034 and a CAGR of 11.5%. It is a different crop system with its own demand drivers, but it shares the same industry classification.

What could slow it

The bear case rests on three assumptions. Fumigant and chemistry restrictions cut treated area faster than substitutes arrive. Growers switch to rotation and resistant varieties. Low-cost generics hold prices down. On those terms 2034 revenue lands at USD 3.5 billion against the USD 4.16 billion base case.

The product mix creates a second exposure. Fumigants carry 34% of 2025 revenue, worth USD 0.816 billion. The line compounds at 4.02% against 6.31% for the market. Its revenue still rises to USD 1.165 billion by 2034, but its share falls to 28%. Because the line is so large, its pace holds the blended rate down by more than any faster line lifts it. No other single change on the product type axis moves the total as much as a change in demand for fumigants.

Regional concentration adds a third. Of Asia Pacific's USD 0.864 billion in 2025, China accounts for USD 0.3 billion, or 34.72% of the region. China reaches USD 0.6 billion by 2034. The report's reading is that regional risk in Asia Pacific is largely country risk under a larger label.

Where the growth sits

Asia Pacific is the leading region at 36% of global revenue, with USD 0.864 billion in 2025 and USD 1.677 billion by 2034. Its share in 2034 is 40.3%. North America holds 27% at USD 0.648 billion and reaches USD 1.019 billion. Europe holds 17%, Latin America 14% and Middle East and Africa 6%. Most of the base and most of the growth sit in the first two regions, so a plan spread evenly across all five over-invests in the smaller ones.

By product type, the 2025 shares are:

  • Fumigants: 34%
  • Organophosphates and Carbamates: 28%
  • Novel Synthetic Chemistries: 17%
  • Microbial Biological Nematicides: 14%
  • Botanical and Natural Extracts: 7%

The report also segments the market by mode of action, crop type, application method, formulation, target nematode, cultivation system, farming practice, distribution channel and end user. Crop types include fruits and vegetables, cereals and grains, oilseeds and pulses, and turf and ornamentals. Application methods include soil treatment, seed treatment, chemigation and foliar application.

The report locates the opening on the product type axis and not the regional one. Share moves toward Microbial Biological Nematicides, from 14% in 2025 to 21% in 2034. Taking a position there does not require displacing the holders of the fumigant base, which is the harder and more expensive contest.

Field monitoring is one place where adjacent technology markets touch this one. The remote sensing technology market lists agriculture and forestry among its application segments. It is forecast at USD 45.8 billion by 2034 at a CAGR of 10.24%. The nematicides data does not link the two markets, so treat them as neighbours and not as a dependency.

For the full segmentation, the company list and the scenario detail, see the nematicides market report.